Regulation of T helper type 2 cell immunity by interleukin-4 and interleukin-13

被引:65
作者
McKenzie, ANJ [1 ]
机构
[1] MRC, Mol Biol Lab, Cambridge CB2 2QH, England
关键词
Th2; immunity; interleukin-4; interleukin-13; helminths; asthma; fibrosis;
D O I
10.1016/S0163-7258(00)00088-7
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Type 2 cytokine responses are typical of immune reactions to parasitic helminth infections, allergies, and asthma, and are characterised by the production of the cytokines interleukin (IL)-4, IL-5, IL-9, and IL-13 by subsets of T helper type 2 (Th2) cells. These cytokines form a complex network of molecular and cellular interactions that mediate protective immunity to worm infection, but also induce inappropriate inflammatory responses to allergic challenge. Although considerable attention has been given to the roles played by IL-4 in Th2 responses, the identification of the related cytokine IL-13 has led to a re-evaluation of how these two molecules combine in the generation of Th2 immunity. Recent reports have highlighted that in certain challenges, IL-4 and IL-13 act in combination to ensure the rapid onset of a Th2-like response. However, these studies have also identified specific responses that are attributable to the individual cytokines. For example, IL-13 appears to play a more dominant role than IL-4 in the expulsion of certain gastrointestinal parasites. In contrast, following schistosome infection, IL-13 induces a detrimental hepatic fibrosis, while IL-4 protects against endotoxemia. These results emphasise the complexity of the cytokine network, and highlight the care that needs to be taken when designing therapeutic intervention. (C) 2000 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:143 / 151
页数:9
相关论文
共 72 条
[1]   cDNA cloning and characterization of the human interleukin 13 receptor alpha chain [J].
Aman, MJ ;
Tayebi, N ;
Obiri, NI ;
Puri, RK ;
Modi, WS ;
Leonard, WJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (46) :29265-29270
[2]   Differences between IL-4Rα-deficient and IL-4-deficient mice reveal a role for IL-13 in the regulation of Th2 responses [J].
Barner, M ;
Mohrs, M ;
Brombacher, F ;
Kopf, M .
CURRENT BIOLOGY, 1998, 8 (11) :669-672
[3]   Serial backcross mapping of multiple loci associated with resistance to Leishmania major in mice [J].
Beebe, AM ;
Mauze, S ;
Schork, NJ ;
Coffman, RL .
IMMUNITY, 1997, 6 (05) :551-557
[4]   Genetic susceptibility to leishmanial infections: Studies in mice and man [J].
Blackwell, JM .
PARASITOLOGY, 1996, 112 :S67-S74
[5]   EOSINOPHILIC INFLAMMATION IN ASTHMA [J].
BOUSQUET, J ;
CHANEZ, P ;
LACOSTE, JY ;
BARNEON, G ;
GHAVANIAN, N ;
ENANDER, I ;
VENGE, P ;
AHLSTEDT, S ;
SIMONYLAFONTAINE, J ;
GODARD, P ;
MICHEL, FB .
NEW ENGLAND JOURNAL OF MEDICINE, 1990, 323 (15) :1033-1039
[6]   ACTIVATED MAST-CELLS PRODUCE INTERLEUKIN-13 [J].
BURD, PR ;
THOMPSON, WC ;
MAX, EE ;
MILLS, FC .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (04) :1373-1380
[7]   Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor alpha chain [J].
Caput, D ;
Laurent, P ;
Kaghad, M ;
Lelias, JM ;
Lefort, S ;
Vita, N ;
Ferrara, P .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (28) :16921-16926
[8]   An IL-13 inhibitor blocks the development of hepatic fibrosis during a T-helper type 2-dominated inflammatory response [J].
Chiaramonte, MG ;
Donaldson, DD ;
Cheever, AW ;
Wynn, TA .
JOURNAL OF CLINICAL INVESTIGATION, 1999, 104 (06) :777-785
[9]  
Chiaramonte MG, 1999, J IMMUNOL, V162, P920
[10]   MECHANISM AND REGULATION OF IMMUNOGLOBULIN ISOTYPE SWITCHING [J].
COFFMAN, RL ;
LEBMAN, DA ;
ROTHMAN, P .
ADVANCES IN IMMUNOLOGY, VOL 54, 1993, 54 :229-270